Cefetamet

Cefetamet

SCHEMBL6567051

CO/N=C(\C(=O)NC1C(=O)N2C(C(=O)O)=C(C)CS[C@@H]12)c1csc(N)n1

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1I2 O75469 6/20 0.79
▸ HTR2C P28335 1/20 0.79
▸ MAPT P10636 3/20 0.76
▸ PPARG P37231 2/20 0.76
▸ SLC22A6 Q4U2R8 2/20 0.76
▸ SLC22A8 Q8TCC7 2/20 0.76
▸ SLC22A11 Q9NSA0 2/20 0.76
▸ ALB P02768 1/20 0.76
▸ PTGS1 P23219 1/20 0.74
▸ PGR P06401 3/20 0.72
▸ PTGS2 P35354 1/20 0.72
▸ TDP1 Q9NUW8 5/20 0.67
▸ APEX1 P27695 3/20 0.67
▸ ABCC4 O15439 3/20 0.67
▸ LMNA P02545 2/20 0.67
▸ L3MBTL1 Q9Y468 2/20 0.67
▸ CYP1A2 P05177 1/20 0.67
▸ PKM P14618 1/20 0.67
▸ HSD17B10 Q99714 1/20 0.67
▸ ALDH1A1 P00352 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cefetamet SCHEMBL27492189 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL10587826 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL8795245 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL7863727 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL11328620 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL10587831 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL151099 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL65620 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL9367206 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL2586142 0.99 NR1I2 (0.78) NR1I2HTR2CMAPTPPARGSLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0612729-B1 Pyridine derivatives, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1997-04-23 — — EP claimed
EP-0187209-B1 PROCESS FOR THE PREPARATION OF CEPHALOSPORINS F. HOFFMANN-LA ROCHE AG (CH) 1992-01-08 — — EP claimed
US-20040087787-A1 Novel thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2004-05-06 — — US disclosed
EP-1399429-A1 1,3,4-OXADIAZOL-2-YL THIOESTERS AND THEIR USE FOR ACYLATING 7-AMINOCEPHALOSPORINS Orchid Chemicals and Pharmaceuticals Ltd (IN) 2004-03-24 — — EP disclosed
EP-1347970-A1 NOVEL THIOESTER DERIVATIVES OF THIAZOLYL ACETIC ACID AND THEIR USE IN THE PREPARATION OF CEPHALOSPORIN COMPOUNDS Orchid Chemicals and Pharmaceuticals Limited (IN) 2003-10-01 — — EP disclosed
WO-2003004477-A1 1,3,4-OXADIAZOL-2-YL THIOESTERS AND THEIR USE FOR ACYLATING 7-AMINOCEPHALOSPORINS ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2003-01-16 — — WO disclosed
WO-2002053563-A1 NOVEL THIOESTER DERIVATIVES OF THIAZOLYL ACETIC ACID AND THEIR USE IN THE PREPARATION OF CEPHALOSPORIN COMPOUNDS ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2002-07-11 — — WO disclosed
US-6388070-B1 CHEMICAL INTERMEDIATE ORCHID CHEMICALS & PHARMACEUTICALS LTD. (IN) 2002-05-14 — — US disclosed
US-6384215-B1 REACTING 4-HALO-2-METHOXYIMINO-3-OXO-BUTYRIC ACID WITH 2-MERCAPTO-1,3,4-OXADIAZOLE TO PRODUCE 2-MERCAPTO-1,3,4-OXADIAZOLYL-4-HALO-2-METHOXYIMINO BUTYRIC ACID; REACTING WITH 7-AMINO-CEPHEM CARBOXYLIC ACID AND THIOUREA ORCHID CHEMICALS & PHARMACEUTICALS LTD. (IN) 2002-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087787-A1 Novel thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds ACOT7, ACACA, COASY NR1I2 2701/4885HTR2C 4739/4885MAPT 2940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback